Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

NCT05201547 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Carboplatin-Paclitaxel
DRUG: Dostarlimab

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]